Drawing for MADE REAL

USPTO serial 86130879

MADE REAL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NEVILLE, BRIAN
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MADE REAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Glenn A. Gundersen

GLENN A. GUNDERSEN DECHERT LLP2929 ARCH ST STE 400PHILADELPHIA, PA 19104-2808UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business management, business strategy, business consultancy and advisory services for the pharmaceutical, medical device, food and healthcare industries; market research, namely, collecting market trends data from providers and patients, data on health economic issues, and competitive intelligence data on the marketplace for pharmaceutical products and medical devices; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; administering customer service programs, namely, operating patient assistance programs for pharmaceutical products and medical devices, and providing access to advocacy groups and counseling for patients to promote patient satisfaction; information and advisory services relating to the foregoingACTIVE—
036Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devicesACTIVE—
042Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; research and development of antibodies for in vitro and in vivo use; custom design and development of chemical reagents and biochemical assays; consulting services for others in the field of design, planning, and project management of scientific research, drug development, and clinical trials; medical and scientific research, namely, designing, organizing, conducting, and managing clinical trials for others; clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; scientific laboratory services; laboratory research services relating to pharmaceuticals, medical devices, biotechnology, biochemicals, antibodies, molecules for drug development, biomarker analysis, pharmacology, toxicology, drug metabolism, pharmacokinetics, biology, immunochemistry, health vaccines, pathology, and isotope chemistry; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of biomarkers, genomics, proteomics, and genotyping; computer software design; development, updating and maintenance of software and databases; data mining; providing temporary use of on-line non-downloadable software for tracking, monitoring, analyzing, and reporting information and statistics in the fields of pharmaceutical and medical device development studies, clinical trials, patient reimbursement and insurance coverage, and biological research; food safety testing and consultation related thereto; scientific consulting and research services relating to food, food packaging, and nutritional chemistry; information and advisory services relating to the foregoingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 20, 2015MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 19, 2015ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 17, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 22, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 22, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 2, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2014DOCKASSIGNED TO EXAMINER—
Dec 12, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance